Of course, it’s in Miller’s interests to pump the prospects of the small-cap biotechs that comprise the bulk of his selection universe—just as it’s in Neuroinvest's (Dr. Harry Tracy’s) interests to pump the prospects of biotechs in the CNS arena. JMHO, FWIW
Dew sometimes you just go overboard.
It's not in their "best interests" which IMHO is a negative connotation.
It is the fields they cover. That is their interest. It's not "pumping".
BTW you appear as others have pointed out to overlook both Miller and Dr. Tracy's criticisms of companies in their "Universe".
I don't have a problem with your disagreements when substantiated by an argument. EPS is a good one in this example. But can you drop the overly wild stuff.